BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6804789)

  • 1. Functional affinity constants of subfragments of immunoglobulin G for Clq.
    Painter RH; Foster DB; Gardner B; Hughes-Jones NC
    Mol Immunol; 1982 Jan; 19(1):127-31. PubMed ID: 6804789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-operation between the pair of C gamma 2 domains in Clq-binding by rabbit IgG.
    Udaka K; Okada M; Utsumi S
    Mol Immunol; 1986 Oct; 23(10):1103-10. PubMed ID: 3491952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the binding of human serum amyloid P component to Clq and Fab gamma.
    Bristow CL; Boackle RJ
    Mol Immunol; 1986 Oct; 23(10):1045-52. PubMed ID: 3099175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common epitopes in Clq and collagen type II.
    Heinz HP; Rubin K; Laurell AB; Loos M
    Mol Immunol; 1989 Feb; 26(2):163-9. PubMed ID: 2465489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
    Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
    Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors.
    Stone GC; Sjöbring U; Björck L; Sjöquist J; Barber CV; Nardella FA
    J Immunol; 1989 Jul; 143(2):565-70. PubMed ID: 2738404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clq binding activity of monomeric IgG].
    Uwatoko S; Aotsuka S; Okawa M; Yokohari R; Aizawa C; Suzuki K
    Arerugi; 1982 Oct; 31(10):1022-8. PubMed ID: 6984822
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.
    van Schravendijk MR; Dwek RA
    Mol Immunol; 1981 Dec; 18(12):1079-85. PubMed ID: 6977701
    [No Abstract]   [Full Text] [Related]  

  • 9. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
    Hamada A; Greene BM
    J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effect of synthetic peptides corresponding to sequences within the CH2 and CH3 domain of human IgG1.
    Sàrmay G; Reguly K; Szigeti R; Klein E; Stanworth DR; Gergely J
    Mol Immunol; 1988 Nov; 25(11):1183-8. PubMed ID: 3146695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clq receptor site on immunoglobulin G.
    Burton DR; Boyd J; Brampton AD; Easterbrook-Smith SB; Emanuel EJ; Novotny J; Rademacher TW; van Schravendijk MR; Sternberg MJ; Dwek RA
    Nature; 1980 Nov; 288(5789):338-44. PubMed ID: 6776418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes.
    Barnett Foster DE; Dorrington KJ; Painter RH
    J Immunol; 1980 May; 124(5):2186-90. PubMed ID: 7365252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants.
    Sasso EH; Barber CV; Nardella FA; Yount WJ; Mannik M
    J Immunol; 1988 May; 140(9):3098-107. PubMed ID: 2452199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
    Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
    Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C1q receptor site on human immunoglobulin G.
    Painter RH
    Can J Biochem Cell Biol; 1984 Jun; 62(6):418-25. PubMed ID: 6380685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of Clq binding to antibody-I. aggregation and/or distortion of IgG vs combining site-transmitted effects.
    Liberti PA; Bausch DM; Schoenberg LM
    Mol Immunol; 1982 Jan; 19(1):143-9. PubMed ID: 6176855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of ovine Ig gamma 2 constant region heavy chain cDNA and molecular modelling of ruminant IgG isotypes.
    Clarkson CA; Beale D; Coadwell JW; Symons DB
    Mol Immunol; 1993 Sep; 30(13):1195-204. PubMed ID: 8413324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.
    Vollertsen RS; McDuffie FC; Bowie EJ
    Clin Exp Immunol; 1983 May; 52(2):423-9. PubMed ID: 6602680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for histidine residues in the immunoglobulin-binding site of human Clq.
    Easterbrook-Smith SB
    Biosci Rep; 1983 Feb; 3(2):135-40. PubMed ID: 6221769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.